Amphastar Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Amphastar Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q3 2024.
  • Amphastar Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 60.7M shares, a 2.48% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 60.7M +1.47M +2.48% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 60.5M +1.41M +2.39% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 60.2M +1.72M +2.94% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 59.4M +1.28M +2.2% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 59.2M +1.23M +2.11% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 59.1M +1.17M +2.03% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 58.4M +945K +1.64% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 58.1M +1.67M +2.96% Dec 31, 2022 10-K 2024-02-29
Q3 2022 58M +1.94M +3.47% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 57.9M +2.16M +3.88% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 57.5M +2.31M +4.19% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 56.4M +1.68M +3.07% Dec 31, 2021 10-K 2023-03-01
Q3 2021 56.1M +1.43M +2.61% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 55.7M +1.36M +2.51% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 55.2M +2.32M +4.39% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 54.8M +2.27M +4.32% Dec 31, 2020 10-K 2022-03-11
Q3 2020 54.6M +2.22M +4.25% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 54.4M +2.16M +4.14% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 52.9M +822K +1.58% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 52.5M +1.06M +2.06% Dec 31, 2019 10-K 2021-03-15
Q3 2019 52.4M +1.52M +2.98% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 52.2M +1.55M +3.06% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 52M +1.57M +3.11% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 51.4M +1.4M +2.8% Dec 31, 2018 10-K 2020-03-16
Q3 2018 50.9M +1.89M +3.86% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 50.7M +1.79M +3.66% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 50.5M +2.47M +5.14% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 50M +2.27M +4.76% Dec 31, 2017 10-K 2019-03-15
Q3 2017 49M +1.48M +3.13% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 48.9M +2.36M +5.07% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 48M +1.9M +4.13% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 47.8M +1.8M +3.93% Dec 31, 2016 10-K 2018-03-14
Q3 2016 47.5M +2.3M +5.09% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 46.5M +1.19M +2.62% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 46.1M +1.44M +3.22% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 46M +1.28M +2.87% Dec 31, 2015 10-K 2017-03-15
Q3 2015 45.2M +561K +1.26% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 45.3M +694K +1.55% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 44.7M Mar 31, 2015 10-Q 2015-05-14
Q4 2014 44.7M +5.91M +15.2% Dec 31, 2014 10-K 2016-03-15
Q3 2014 44.6M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 44.6M Jun 30, 2014 10-Q 2014-08-13
Q4 2013 38.8M Dec 31, 2013 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.